|
UCB will pay $650m upfront and up to $500m in future milestones.
|
 |
|
The order sets out to speed up the review of psychedelics, while supporting research into this burgeoning field.
|
|
|
The biotech will primarily focus on taking the oral and injectable form of its lead candidate, ribupatide, through late-stage obesity trials.
|
|
|
Enflonsia is contraindicated in infants with hypersensitivity to its active substance or excipients.
|
|
|
The regulator requires Lilly to evaluate the “unexpected serious” risks associated with Foundayo.
|
|
|
Cochrane’s research looked at 17 clinical trials of anti-amyloid drugs in Alzheimer’s disease.
|
|
